Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
0.040 | 1.000 | 4 | 2013 | 2019 | |||||||||
|
1.000 | 0.240 | 10 | 8064037 | missense variant | T/A | snv |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Nervous System Diseases; Endocrine System Diseases; Otorhinolaryngologic Diseases | 0.800 | 1.000 | 3 | 2000 | 2015 | ||||||||
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.030 | 1.000 | 3 | 2013 | 2017 | ||||||||
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 3 | 2013 | 2018 | ||||||||
|
1.000 | 0.120 | 10 | 8062759 | intron variant | C/T | snv | 0.49 |
|
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases | 0.800 | 1.000 | 2 | 2014 | 2019 | |||||||
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.020 | 1.000 | 2 | 2013 | 2017 | ||||||||
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
0.020 | 1.000 | 2 | 2013 | 2015 | |||||||||
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
0.020 | 1.000 | 2 | 2013 | 2017 | |||||||||
|
0.752 | 0.320 | 10 | 8062245 | intron variant | C/A;T | snv |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 2 | 2013 | 2015 | ||||||||
|
1.000 | 0.120 | 10 | 8051071 | non coding transcript exon variant | G/T | snv | 0.87 | 0.86 |
|
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | 0.800 | 1.000 | 2 | 2010 | 2013 | ||||||
|
0.925 | 0.080 | 10 | 8064539 | intron variant | C/T | snv | 0.60 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2007 | 2009 | |||||||
|
0.925 | 0.080 | 10 | 8064539 | intron variant | C/T | snv | 0.60 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.020 | 0.500 | 2 | 2007 | 2009 | |||||||
|
1.000 | 0.240 | 10 | 8073787 | stop gained | C/T | snv |
|
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Nervous System Diseases; Endocrine System Diseases; Otorhinolaryngologic Diseases | 0.710 | 1.000 | 1 | 2020 | 2020 | ||||||||
|
0.925 | 0.240 | 10 | 8073747 | missense variant | A/G;T | snv | 4.0E-06 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.160 | 10 | 8074635 | 3 prime UTR variant | G/A | snv | 0.81 |
|
Infections; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.925 | 0.160 | 10 | 8074635 | 3 prime UTR variant | G/A | snv | 0.81 |
|
Respiratory Tract Diseases; Immune System Diseases; Otorhinolaryngologic Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.882 | 0.200 | 10 | 8073399 | intron variant | C/A;T | snv |
|
0.700 | 1.000 | 1 | 2016 | 2016 | |||||||||
|
0.882 | 0.200 | 10 | 8073399 | intron variant | C/A;T | snv |
|
Pathological Conditions, Signs and Symptoms; Respiratory Tract Diseases; Otorhinolaryngologic Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.200 | 10 | 8073399 | intron variant | C/A;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 0.200 | 10 | 8073399 | intron variant | C/A;T | snv |
|
Infections | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||||
|
0.925 | 0.080 | 10 | 8062378 | intron variant | A/G;T | snv |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.925 | 0.080 | 10 | 8062378 | intron variant | A/G;T | snv |
|
Respiratory Tract Diseases; Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.925 | 0.080 | 10 | 8069546 | missense variant | C/A;G | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 10 | 8069546 | missense variant | C/A;G | snv | 4.0E-06; 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||||
|
0.925 | 0.080 | 10 | 8049414 | intron variant | A/C;G | snv |
|
Immune System Diseases; Hemic and Lymphatic Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 |